nach oben

Erschienen in:

06.06.2018 | Original Article

The relationship between sleep and cognitive function in patients with prediabetes and type 2 diabetes

verfasst von: Sunee Saetung, Hataikarn Nimitphong, Nantaporn Siwasaranond, Rungtip Sumritsopak, Panitha Jindahra, Orapitchaya Krairit, Ammarin Thakkinstian, Thunyarat Anothaisintawee, Sirimon Reutrakul

Erschienen in: Acta Diabetologica | Ausgabe 9/2018

Einloggen, um Zugang zu erhalten

Abstract

Aims

Diabetes is linked to cognitive impairment. Sleep plays a role in memory consolidation. Sleep disturbances, commonly found in patients with diabetes, were shown to be related to cognitive dysfunction. This study explored the role of sleep in cognitive function of patients with abnormal glucose tolerance.

Methods

A total of 162 patients (81 type 2 diabetes and 81 prediabetes) participated. Sleep duration and sleep efficiency (an indicator of sleep quality) were obtained using 7-day actigraphy recordings. Obstructive sleep apnea (OSA) was screened using an overnight in-home monitor. Cognitive function was assessed using the Montreal Cognitive Assessment (MoCA). Three sub-scores of MoCA, visuoexecutive function, attention and delayed recall, were also analyzed.

Results

Mean age was 54.8 (10.2) years. OSA was diagnosed in 123 participants (76.9%). Mean sleep duration was 6.0 (1.0) h and sleep efficiency was 82.7 (8.1) %. Sleep duration and OSA severity were not related to MoCA scores. Higher sleep efficiency was associated with higher MoCA scores (p = 0.003), and having diabetes (vs. prediabetes) was associated with lower MoCA scores (p = 0.001). After adjusting covariates, both having diabetes (vs. prediabetes) (B = − 1.137, p = 0.002) and sleep efficiency (B = 0.085, p < 0.001) were independently associated with MoCA scores. In addition, diabetes (B = − 0.608, p < 0.001) and sleep efficiency (B = 0.038, p < 0.001) were associated with visuoexecutive function. Sleep parameters were not related to delayed recall or attention scores.

Conclusion

Lower sleep efficiency is independently associated with lower cognitive function in patients with abnormal glucose tolerance. Whether sleep optimization may improve cognitive function in these patients should be explored.

Moheet A, Mangia S, Seaquist ER (2015) Impact of diabetes on cognitive function and brain structure. Ann N Y Acad Sci 1353:60–71. https://doi.org/10.1111/nyas.12807 CrossRefPubMedPubMedCentral

American Psychiatric Association (2013) Diagnostic and statistical manual of mental disorders, Fifth Edition (DSM-5). American Psychiatric Publishing, Washington, D.C.CrossRef

Simó R, Ciudin A, Simó-Servat O, Hernández C (2017) Cognitive impairment and dementia: a new emerging complication of type 2 diabetes—the diabetologist’s perspective. Acta Diabetol 54:417–424. https://doi.org/10.1007/s00592-017-0970-5 CrossRefPubMed

Manschot SM, Brands AM, van der Grond J et al (2006) Brain magnetic resonance imaging correlates of impaired cognition in patients with type 2 diabetes. Diabetes 55:1106–1113CrossRefPubMed

Grodstein F, Chen J, Wilson RS, Manson JE (2001) Type 2 diabetes and cognitive function in community-dwelling elderly women. Diabetes Care 24:1060–1065CrossRefPubMed

Chatterjee S, Peters SA, Woodward M et al (2016) Type 2 diabetes as a risk factor for dementia in women compared with men: a pooled analysis of 2.3 million people comprising more than 100,000 cases of dementia. Diabetes Care 39:300–307. https://doi.org/10.2337/dc15-1588 PubMedCrossRef

Biessels GJ, Reijmer YD (2014) Brain changes underlying cognitive dysfunction in diabetes: what can we learn from MRI? Diabetes 63:2244–2252. https://doi.org/10.2337/db14-0348 CrossRefPubMed

van Harten B, de Leeuw FE, Weinstein HC, Scheltens P, Biessels GJ (2006) Brain imaging in patients with diabetes: a systematic review. Diabetes Care 29:2539–2548. https://doi.org/10.2337/dc06-1637 CrossRefPubMed

Hassing LB, Grant MD, Hofer SM et al (2004) Type 2 diabetes mellitus contributes to cognitive decline in old age: a longitudinal population-based study. J Int Neuropsychol Soc 10:599–607. https://doi.org/10.1017/S1355617704104165 CrossRefPubMed

10.

Kanaya AM, Barrett-Connor E, Gildengorin G, Yaffe K (2004) Change in cognitive function by glucose tolerance status in older adults: a 4-year prospective study of the Rancho Bernardo study cohort. Arch Intern Med 164:1327–1333. https://doi.org/10.1001/archinte.164.12.1327 CrossRefPubMed

11.

Hugenschmidt CE, Lovato JF, Ambrosius WT et al (2014) The cross-sectional and longitudinal associations of diabetic retinopathy with cognitive function and brain MRI findings: the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. Diabetes Care 37:3244–3252. https://doi.org/10.2337/dc14-0502 CrossRefPubMedPubMedCentral

12.

Cukierman-Yaffe T, Gerstein HC, Williamson JD et al (2009) Relationship between baseline glycemic control and cognitive function in individuals with type 2 diabetes and other cardiovascular risk factors: the action to control cardiovascular risk in diabetes-memory in diabetes (ACCORD-MIND) trial. Diabetes Care 32:221–226. https://doi.org/10.2337/dc08-1153 CrossRefPubMedPubMedCentral

13.

Sullivan MD, Katon WJ, Lovato LC et al (2013) Association of depression with accelerated cognitive decline among patients with type 2 diabetes in the ACCORD-MIND trial. JAMA Psychiatry 70:1041–1047. https://doi.org/10.1001/jamapsychiatry.2013.1965 CrossRefPubMedPubMedCentral

14.

Snowden MB, Steinman LE, Bryant LL et al (2017) Dementia and co-occurring chronic conditions: a systematic literature review to identify what is known and where are the gaps in the evidence? Int J Geriatr Psychiatry 32:357–371. https://doi.org/10.1002/gps.4652 CrossRefPubMedPubMedCentral

15.

Punthakee Z, Miller ME, Launer LJ et al (2012) Poor cognitive function and risk of severe hypoglycemia in type 2 diabetes: post hoc epidemiologic analysis of the ACCORD trial. Diabetes Care 35:787–793. https://doi.org/10.2337/dc11-1855 CrossRefPubMedPubMedCentral

16.

Scullin MK, Bliwise DL (2015) Sleep, cognition, and normal aging: integrating a half century of multidisciplinary research. Perspect Psychol Sci 10:97–137. https://doi.org/10.1177/1745691614556680 CrossRefPubMedPubMedCentral

17.

Virta JJ, Heikkila K, Perola M et al (2013) Midlife sleep characteristics associated with late life cognitive function. Sleep 36:1533–1541. https://doi.org/10.5665/sleep.3052 (1541A) CrossRefPubMedPubMedCentral

18.

Xu L, Jiang CQ, Lam TH et al (2014) Sleep duration and memory in the elderly Chinese: longitudinal analysis of the Guangzhou Biobank Cohort Study. Sleep 37:1737–1744. https://doi.org/10.5665/sleep.4162 CrossRefPubMedPubMedCentral

19.

Keage HA, Banks S, Yang KL (2012) What sleep characteristics predict cognitive decline in the elderly? Sleep Med 13:886–892. https://doi.org/10.1016/j.sleep.2012.02.003 CrossRefPubMed

20.

Benito-Leon J, Louis ED, Bermejo-Pareja F (2013) Cognitive decline in short and long sleepers: a prospective population-based study (NEDICES). J Psychiatr Res 47:1998–2003. https://doi.org/10.1016/j.jpsychires.2013.09.007 CrossRefPubMed

21.

Tworoger SS, Lee S, Schernhammer ES, Grodstein F (2006) The association of self-reported sleep duration, difficulty sleeping, and snoring with cognitive function in older women. Alzheimer Dis Assoc Disord 20:41–48. https://doi.org/10.1097/01.wad.0000201850.52707.80 CrossRefPubMed

22.

Bubu OM, Brannick M, Mortimer J et al (2017) Sleep, cognitive impairment, and Alzheimer’s disease: a systematic review and meta-analysis. Sleep. https://doi.org/10.1093/sleep/zsw032 PubMedCrossRef

23.

Blackwell T, Yaffe K, Laffan A et al (2014) Associations of objectively and subjectively measured sleep quality with subsequent cognitive decline in older community-dwelling men: the MrOS sleep study. Sleep 37:655–663. https://doi.org/10.5665/sleep.3562 CrossRefPubMedPubMedCentral

24.

Reutrakul S, Van Cauter E (2014) Interactions between sleep, circadian function, and glucose metabolism: implications for risk and severity of diabetes. Ann N Y Acad Sci 1311:151–173. https://doi.org/10.1111/nyas.12355 CrossRefPubMed

25.

Lal C, Strange C, Bachman D (2012) Neurocognitive impairment in obstructive sleep apnea. Chest 141:1601–1610. https://doi.org/10.1378/chest.11-2214 CrossRefPubMed

26.

Boland LL, Shahar E, Iber C (2002) Measures of cognitive function in persons with varying degrees of sleep-disordered breathing: the Sleep Heart Health Study. J Sleep Res 11:265–272CrossRefPubMed

27.

Olaithe M, Skinner TC, Hillman D, Eastwood PE, Bucks RS (2015) Cognition and nocturnal disturbance in OSA: the importance of accounting for age and premorbid intelligence. Sleep Breath 19:221–230. https://doi.org/10.1007/s11325-014-1000-2 CrossRefPubMed

28.

Kushida CA, Nichols DA, Holmes TH et al (2012) Effects of continuous positive airway pressure on neurocognitive function in obstructive sleep apnea patients: the Apnea Positive Pressure Long-term Efficacy Study (APPLES). Sleep 35:1593–1602. https://doi.org/10.5665/sleep.2226 CrossRefPubMedPubMedCentral

29.

Holingue C, Wennberg A, Berger S, Polotsky VY, Spira AP (2018) Disturbed sleep and diabetes: a potential nexus of dementia risk. Metab Clin Exp. https://doi.org/10.1016/j.metabol.2018.01.021 PubMedCrossRef

30.

Li H, Gong Q, Shao J, Liu X, Zhao Y (2014) Cognitive dysfunction in type 2 diabetes patients accompanied with obstructive sleep apnea syndrome. Pak J Med Sci 30:1388–1392. https://doi.org/10.12669/pjms.306.5861 PubMedPubMedCentralCrossRef

31.

American Diabetes Association (2017) Standards of medical care in diabetes-2017. Diabetes Care 40:S1–S142CrossRef

32.

Tangwongchai S, Charenboon T, Phanasathit M et al (2009) The validity of thai version of the montreal cognitive assessment (MoCA-T). Dement Neuropsychol 3:172

33.

Radloff L (1977) The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas 1:385–401CrossRef

34.

Trangkasombat U, Larpboonsarp V, Havanond P (1997) CES-D as a screen for depression in adolescents. J Psychiatr Assoc Thail 42:2–13

35.

Ploylermsang C (2005) Contructive validity of the CES-D depression sclae among student. IJPS 1:25–39

36.

Yuceege M, Firat H, Demir A, Ardic S (2013) Reliability of the Watch-PAT 200 in detecting sleep apnea in highway bus drivers. J Clin Sleep Med 9:339–344. https://doi.org/10.5664/jcsm.2584 PubMedPubMedCentralCrossRef

37.

Zou D, Grote L, Peker Y, Lindblad U, Hedner J (2006) Validation a portable monitoring device for sleep apnea diagnosis in a population based cohort using synchronized home polysomnography. Sleep 29:367–374CrossRefPubMed

38.

Lambiase MJ, Gabriel KP, Kuller LH, Matthews KA (2014) Sleep and executive function in older women: the moderating effect of physical activity. J Gerontol Ser A Biol Sci Med Sci 69:1170–1176. https://doi.org/10.1093/gerona/glu038 CrossRef

39.

Holanda FWNJ., de Almondes KM (2016) Sleep and executive functions in older adults: a systematic review. Dement Neuropsychol 10:185–197. https://doi.org/10.1590/s1980-5764-2016dn1003004 CrossRef

40.

Lim AS, Kowgier M, Yu L, Buchman AS, Bennett DA (2013) Sleep fragmentation and the risk of incident Alzheimer’s disease and cognitive decline in older persons. Sleep 36:1027–1032. https://doi.org/10.5665/sleep.2802 CrossRefPubMedPubMedCentral

41.

Yaffe K, Blackwell T, Barnes DE, Ancoli-Israel S, Stone KL (2007) Preclinical cognitive decline and subsequent sleep disturbance in older women. Neurology 69:237–242. https://doi.org/10.1212/01.wnl.0000265814.69163.da CrossRefPubMed

42.

Blackwell T, Yaffe K, Ancoli-Israel S et al (2006) Poor sleep is associated with impaired cognitive function in older women: the study of osteoporotic fractures. J Gerontol Ser A Biol Sci Med Sci 61:405–410CrossRef

43.

Ju YE, McLeland JS, Toedebusch CD et al (2013) Sleep quality and preclinical Alzheimer disease. JAMA Neurol 70:587–593. https://doi.org/10.1001/jamaneurol.2013.2334 CrossRefPubMedPubMedCentral

44.

Lim AS, Yu L, Kowgier M (2013) Modification of the relationship of the apolipoprotein E epsilon4 allele to the risk of Alzheimer disease and neurofibrillary tangle density by sleep. JAMA Neurol 70:1544–1551. https://doi.org/10.1001/jamaneurol.2013.4215 CrossRefPubMed

45.

Stamatakis KA, Punjabi NM (2010) Effects of sleep fragmentation on glucose metabolism in normal subjects. Chest 137:95–101. https://doi.org/10.1378/chest.09-0791 CrossRefPubMed

46.

Willette AA, Bendlin BB, Starks EJ et al (2015) Association of insulin resistance with cerebral glucose uptake in late middle-aged adults at risk for Alzheimer disease. JAMA Neurol 72:1013–1020. https://doi.org/10.1001/jamaneurol.2015.0613 CrossRefPubMedPubMedCentral

47.

Ekblad LL, Rinne JO, Puukka P et al (2017) Insulin resistance predicts cognitive decline: an 11-year follow-up of a nationally representative adult population sample. Diabetes Care. https://doi.org/10.2337/dc16-2001 CrossRefPubMed

48.

Lucassen EA, Piaggi P, Dsurney J et al (2014) Sleep extension improves neurocognitive functions in chronically sleep-deprived obese individuals. PLoS One 9:e84832. https://doi.org/10.1371/journal.pone.0084832 CrossRefPubMedPubMedCentral

49.

Allain H, Patat A, Lieury A et al (1995) Comparative study of the effects of zopiclone (7.5 mg), zolpidem, flunitrazepam and a placebo on nocturnal cognitive performance in healthy subjects, in relation to pharmacokinetics. Eur Psychiatry 10(Suppl 3):129 s–135 s. https://doi.org/10.1016/0924-9338(96)80094-0 CrossRef

50.

Sattar L, Renneboog B, Decaux G (2017) Hyperglycemia induces attention and gait deficits in diabetic mellitus patients. Acta Diabetol 54:953–959. https://doi.org/10.1007/s00592-017-1034-6 CrossRefPubMed

51.

Sang YM, Wang LJ, Mao HX, Lou XY, Zhu YJ (2018) The association of short-term memory and cognitive impairment with ghrelin, leptin, and cortisol levels in non-diabetic and diabetic elderly individuals. Acta Diabetol. https://doi.org/10.1007/s00592-018-1111-5 PubMedCrossRef

52.

Trento M, Charrier L, Salassa M et al (2015) Depression, anxiety and cognitive function in patients with type 2 diabetes: an 8-year prospective observational study. Acta Diabetol 52:1157–1166. https://doi.org/10.1007/s00592-015-0806-0 CrossRefPubMed

53.

van Bussel FC, Backes WH, van Veenendaal TM et al (2016) Functional brain networks are altered in type 2 diabetes and prediabetes: signs for compensation of cognitive decrements? The Maastricht Study. Diabetes 65:2404–2413. https://doi.org/10.2337/db16-0128 CrossRefPubMed

Titel: The relationship between sleep and cognitive function in patients with prediabetes and type 2 diabetes
verfasst von: Sunee Saetung
Hataikarn Nimitphong
Nantaporn Siwasaranond
Rungtip Sumritsopak
Panitha Jindahra
Orapitchaya Krairit
Ammarin Thakkinstian
Thunyarat Anothaisintawee
Sirimon Reutrakul
Publikationsdatum: 06.06.2018
Verlag: Springer Milan
Erschienen in: Acta Diabetologica / Ausgabe 9/2018
Print ISSN: 0940-5429
Elektronische ISSN: 1432-5233
DOI: https://doi.org/10.1007/s00592-018-1166-3

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

25.04.2024 Allergien und Intoleranzreaktionen Nachrichten

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Aims

Methods

Results

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 9/2018

Association analysis of copy number variations in type 2 diabetes-related susceptible genes in a Chinese population

Can HbA1c combined with fasting plasma glucose help to assess priority for GCK-MODY vs HNF1A-MODY genetic testing?

Association of branched chain amino acids related variant rs1440581 with risk of incident diabetes and longitudinal changes in insulin resistance in Chinese

Aerobic training improves platelet function in type 2 diabetic patients: role of microRNA-130a and GPIIb

The response of serum Glypican-4 levels and its potential regulatory mechanism to endurance training and chamomile flowers’ hydroethanolic extract in streptozotocin–nicotinamide-induced diabetic rats